Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ANAVEX-371 by Anavex Life Sciences for Schizophrenia: Likelihood of Approval
ANAVEX-371 is under clinical development by Anavex Life Sciences and currently in Phase II for Schizophrenia. According to GlobalData, Phase...
Data Insights
ANAVEX-371 by Anavex Life Sciences for Frontotemporal Dementia (FTD): Likelihood of Approval
ANAVEX-371 is under clinical development by Anavex Life Sciences and currently in Phase I for Frontotemporal Dementia (FTD). According to...